Rate of survival survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line, Tumor Cells, Cultured Cell Line Bile Ducts, Intrahepatic Lymph Nodes Tumor Cells, Cultured Neurons

Organisms6

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Mice, Transgenic Mice, Nude Rats, Sprague-Dawley

Diseases61

Neoplasm Recurrence, Local Lung Neoplasms Liver Neoplasms Adenocarcinoma Breast Neoplasms Lymphatic Metastasis Neoplasm Metastasis Carcinoma, Squamous Cell Disease Progression Carcinoma, Hepatocellular Recurrence Carcinoma, Non-Small-Cell Lung Brain Neoplasms Postoperative Complications Stomach Neoplasms Colorectal Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Carcinoma Neoplasms Esophageal Neoplasms Disease Models, Animal Bone Neoplasms Melanoma Ovarian Neoplasms Bile Duct Neoplasms Heart Arrest Glioblastoma Rectal Neoplasms Sarcoma Kidney Neoplasms Cholangiocarcinoma Head and Neck Neoplasms Prostatic Neoplasms Kidney Failure, Chronic Osteosarcoma Lymphoma, Non-Hodgkin Multiple Myeloma Skin Neoplasms Glioma Colonic Neoplasms Prosthesis Failure Carcinoma, Renal Cell Carcinoma, Small Cell Liver Failure Nasopharyngeal Neoplasms Leukemia, Myeloid, Acute Hodgkin Disease Acute Disease Lymphoma, Large B-Cell, Diffuse Precursor Cell Lymphoblastic Leukemia-Lymphoma Cadaver Soft Tissue Neoplasms Sepsis Mouth Neoplasms Urinary Bladder Neoplasms Out-of-Hospital Cardiac Arrest Peritoneal Neoplasms Carcinoma, Pancreatic Ductal Lymphoma Central Nervous System Neoplasms

Chemicals and Drugs49

Antineoplastic Agents Tumor Markers, Biological Cisplatin Doxorubicin Cyclophosphamide Fluorouracil Vincristine Prednisone Etoposide Immunosuppressive Agents Deoxycytidine Survival of Motor Neuron 1 Protein Antimetabolites, Antineoplastic RNA, Messenger Vinblastine Antibodies, Monoclonal Methotrexate Paclitaxel Proto-Oncogene Proteins Carboplatin Dacarbazine Tumor Suppressor Protein p53 Bleomycin Neoplasm Proteins Cytarabine Leucovorin Phosphatidylinositol 3-Kinases Antineoplastic Agents, Alkylating Taxoids RNA, Small Interfering Antibodies, Monoclonal, Humanized Organoplatinum Compounds Protein-Serine-Threonine Kinases Receptor, erbB-2 Ifosfamide Antineoplastic Agents, Phytogenic Cryoprotective Agents bcl-X Protein Ki-67 Antigen Survival of Motor Neuron 2 Protein Recombinant Proteins Camptothecin Melphalan Pyrimidines DNA-Binding Proteins Protein Kinase Inhibitors Cytokines alpha-Fetoproteins Procarbazine

Analytical, Diagnostic and Therapeutic Techniques and Equipment95

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Neoplasm Staging Prognosis Follow-Up Studies Proportional Hazards Models Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Multivariate Analysis Risk Factors Prospective Studies Chemotherapy, Adjuvant Immunohistochemistry Actuarial Analysis Cohort Studies Liver Transplantation Registries Radiotherapy, Adjuvant Hepatectomy Predictive Value of Tests Risk Assessment Drug Administration Schedule Kidney Transplantation Life Tables Transplantation, Homologous Remission Induction Reoperation Radiotherapy Dosage Disease Models, Animal Lymph Node Excision Neoadjuvant Therapy SEER Program Incidence Cardiopulmonary Resuscitation Salvage Therapy Reverse Transcriptase Polymerase Chain Reaction Gastrectomy Radiotherapy Chi-Square Distribution Cause of Death Chemoembolization, Therapeutic Probability Analysis of Variance Patient Selection Chemoradiotherapy Blotting, Western Palliative Care Dose Fractionation Treatment Failure Neoplasm Grading Heart Transplantation Gene Expression Profiling Cryopreservation Clinical Trials as Topic Tumor Burden Transplantation, Autologous Esophagectomy Severity of Illness Index Pneumonectomy Prosthesis Failure Regression Analysis Randomized Controlled Trials as Topic Preoperative Care Models, Biological Brachytherapy Hematopoietic Stem Cell Transplantation Radiotherapy, High-Energy Bone Marrow Transplantation Tissue Array Analysis Renal Dialysis Pancreas Transplantation Infusions, Intravenous Dose-Response Relationship, Radiation Statistics, Nonparametric Immunoenzyme Techniques Prosthesis Design Pancreatectomy Tomography, X-Ray Computed Immunosuppression Drug Therapy, Combination Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Random Allocation Hospital Mortality Risk Chemoradiotherapy, Adjuvant Stem Cell Transplantation Postoperative Care Life Expectancy Clinical Trials, Phase III as Topic Xenograft Model Antitumor Assays

Phenomena and Processes27

Cell Survival Graft Survival Time Factors Apoptosis Signal Transduction Graft Rejection Cell Proliferation Gene Expression Regulation, Neoplastic Mutation Tissue Survival Dose-Response Relationship, Drug Chi-Square Distribution Microbial Viability Probability Cell Death Drug Resistance, Neoplasm Longevity Cell Differentiation Phosphorylation Cell Division Up-Regulation Gene Expression Dose-Response Relationship, Radiation Pregnancy Phenotype Risk Cell Movement

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Life Tables SEER Program Incidence Cause of Death Hospital Mortality Life Expectancy Molecular Sequence Data

Named Groups4

Tissue Donors Infant, Newborn Survivors Living Donors

Health Care41

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Risk Factors Prospective Studies Actuarial Analysis Cohort Studies Age Factors Registries Predictive Value of Tests Risk Assessment Life Tables SEER Program Incidence Chi-Square Distribution Cause of Death Probability Analysis of Variance Patient Selection Palliative Care Treatment Failure Sex Factors Clinical Trials as Topic Severity of Illness Index Regression Analysis Randomized Controlled Trials as Topic Preoperative Care Dose-Response Relationship, Radiation Statistics, Nonparametric Random Allocation Hospital Mortality Risk Postoperative Care Life Expectancy Clinical Trials, Phase III as Topic

Geographicals3

Japan United States France

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Survival Rate Cell Survival Disease-Free Survival Survival Analysis Survival Graft Survival Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Time Factors Neoplasm Staging Prognosis Follow-Up Studies Proportional Hazards Models Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Lung Neoplasms Multivariate Analysis Apoptosis Liver Neoplasms Adenocarcinoma Antineoplastic Agents Tumor Markers, Biological Risk Factors Breast Neoplasms Prospective Studies Lymphatic Metastasis Chemotherapy, Adjuvant Immunohistochemistry Neoplasm Metastasis Actuarial Analysis Cisplatin Cohort Studies Carcinoma, Squamous Cell Age Factors Liver Transplantation Disease Progression Cell Line, Tumor Carcinoma, Hepatocellular Signal Transduction Recurrence Registries Carcinoma, Non-Small-Cell Lung Brain Neoplasms Doxorubicin Cyclophosphamide Radiotherapy, Adjuvant Fluorouracil Postoperative Complications Vincristine Stomach Neoplasms Mice, Inbred C57BL Hepatectomy Colorectal Neoplasms Graft Rejection Predictive Value of Tests Risk Assessment Neoplasm Invasiveness Pancreatic Neoplasms Drug Administration Schedule Kidney Transplantation Life Tables Cell Proliferation Transplantation, Homologous Remission Induction Reoperation Carcinoma Neoplasms Esophageal Neoplasms Cells, Cultured Radiotherapy Dosage Disease Models, Animal Gene Expression Regulation, Neoplastic Prednisone Lymph Node Excision Neoadjuvant Therapy SEER Program Incidence Etoposide Bone Neoplasms Tissue Donors Mutation Melanoma Ovarian Neoplasms Mice, Inbred BALB C Cardiopulmonary Resuscitation Tissue Survival Immunosuppressive Agents Mice, Knockout Dose-Response Relationship, Drug Salvage Therapy Bile Duct Neoplasms Deoxycytidine Heart Arrest Reverse Transcriptase Polymerase Chain Reaction Gastrectomy Glioblastoma Rectal Neoplasms Radiotherapy

No FAQ available that match "rate of survival survival rate"